"10.1371_journal.pone.0034833","plos one","2012-04-25T00:00:00Z","Charles Lu; David J Stewart; J Jack Lee; Lin Ji; Rajagopal Ramesh; Gitanjali Jayachandran; Maria I Nunez; Ignacio I Wistuba; Jeremy J Erasmus; Marshall E Hicks; Elizabeth A Grimm; James M Reuben; Veerabhadran Baladandayuthapani; Nancy S Templeton; John D McMannis; Jack A Roth","The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; University of Oklahoma Health Sciences Center and Stephenson Cancer Center, Oklahoma City, Oklahoma, United States of America; Gradalis Inc, Carrollton, Texas, United States of America","Conceived and designed the experiments: CL DJS JJL LJ GJ MIN IIW EAG JMR JAR. Performed the experiments: CL DJS LJ GJ MIN IIW JMR JDM. Analyzed the data: CL DJS JJL LJ RR GJ MIN IIW JJE MEH EAG JMR VB. Contributed reagents/materials/analysis tools: JJL LJ RR GJ MIN IIW JJE MEH EAG JMR VB JDM. Wrote the paper: CL DJS JJL LJ RR GJ MIN IIW JJE MEH EAG JMR VB NST JAR.","CL: Patent-TUSC2 Therapeutic Response Markers (pending), Co-Inventor JAR: Consultancy, grants, stock: Genprex, Inc.; Patents pending and issued: TUSC2/FUS1 NST: Novel DNA:liposome complexes for increased systemic delivery and gene expression. United States Letters Patent No. 6,413,544 B1 issued July 2, 2002. United States Patent No. 6,770,291 B2 issued August 3, 2004. International Publication Number: WO 98/07408. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","04","Charles Lu","CL",16,TRUE,10,8,13,15,TRUE,TRUE,FALSE,0,NA,FALSE
